Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

Convatec announced that it received FDA approval for the delivery of a Parkinson's disease therapy through its Neria Guard ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin ...

Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...

LifePlus announced the clinical validation of its non-invasive and cuffless wearable for continuous glucose and blood ...